EGFR and glioblastoma: More than 50% of glioblastomas with EGFR amplification also contain the EGFRvIII gene mutation, which is characterized by the deletion of exons 2 to 7, resulting in a sense mutation with a truncated extracellular domain and ligand-independent constitutive activity (32).